Journal of Nephrology

Papers
(The TQCC of Journal of Nephrology is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Osmotic demyelination syndrome and thoughts on its prevention100
Prediction of risk factors and outcomes of neonatal acute kidney injury32
Calcium pyrophosphate deposition disease involving “the largest” Bursa in the human body28
NGAL/hepcidin-25 ratio and AKI subtypes in patients following cardiac surgery: a prospective observational study28
Peri-operative risk factors of chronic kidney disease after liver transplantation27
Hyperkalemia excursions and risk of mortality and hospitalizations in hemodialysis patients: results from DOPPS-Italy26
Membranous nephropathy in a patient with COVID-19 infection24
Kidney transplant in patients with atypical hemolytic uremic syndrome in the anti-C5 era: single-center experience with tailored Eculizumab23
Correction to: Renal histology across the stages of chronic kidney disease22
Correction to: Prediction of risk factors and outcomes of neonatal acute kidney injury20
Expanding the variability of the ADPKD-GANAB clinical phenotype in a family of Italian ancestry19
Clinical outcome of short daily hemodialysis in the elderly18
In-center nocturnal hemodialysis improves health-related quality of life for patients with end-stage renal disease18
COVID–19 and chronic kidney disease: an updated overview of reviews17
Therapeutic advances in ADPKD: the future awaits16
Risk of chronic kidney disease in women with a history of preterm delivery: Tehran Lipid and Glucose Study15
A clinical study on the changing dynamics of disease severity, management strategies and outcomes of COVID-19 in patients requiring haemodialysis15
Long-term follow-up of congenital anomalies of the kidney and urinary tract diagnosed in utero: a longitudinal study14
COVID-19-associated atypical hemolytic uremic syndrome and use of Eculizumab therapy14
Wars and kidney patients: a statement by the European Kidney Health Alliance related to the Russian-Ukrainian conflict13
Comparison of 30-day case-fatality rate between dialysis and transplant Covid-19 patients: a propensity score matched cohort study12
Nephrology, renal medicine, kidney doctors: is the discussion about the name of the rose much ado about nothing?12
“Black” kidneys in MRI of a patient with hemolytic anemia12
The innate immune system in human kidney inflammaging12
Calcifediol supplementation in adults on hemodialysis: a randomized controlled trial11
Playing with variety; enjoying heterogeneity in the garden of nephrology: JN spring issue 202111
Using an international online forum to explore perspectives of caregivers of patients with chronic kidney disease10
Significance of regulatory T cells in children with idiopathic nephrotic syndrome9
Plasmatic osteopontin and vascular access dysfunction in hemodialysis patients: a cross-sectional, case–control study (The OSMOSIS Study)9
A long-term nationwide study on chronic kidney disease-related mortality in Italy: trends and associated comorbidity9
Survivors of COVID-19 mostly recover from tubular proteinuria and acute kidney injury after hospital discharge8
Lessons for the clinical nephrologist: recurrent pregnancy-associated thrombotic microangiopathy (TMA) with a known complement mutation and features of preeclampsia; a diagnostic and therapeutic dilem8
Intraperitoneal extension of the peritoneal dialysis catheter—a new technique for catheter implantation in patients with obesity8
Patient and staff experiences of remote kidney healthcare: lessons learnt from COVID-198
COVID-19 in a kidney transplant recipient treated with eculizumab for atypical hemolytic uremic syndrome: a case report8
End of the year issue: is a magic pill on its way? We can always dream8
The virus doesn’t go on vacation8
0.085253953933716